References
- Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58(5):826–850.
- Gelfand JM, Feldman SR, Stern RS, Thomas J, Rolstad T, Margolis DJ. Determinants of quality of life in patients with psoriasis: A study from US population. J Am Acad Dermatol. 2004;51:704–708.
- Gottlieb AB, Matheson RT, Lowe N, Krueger GG, Kang S, Goffe BS, A randomized trial of etanercept as monotherapy for psoriasis. Arch Dermatol. 2003;139:1627–1632.
- Menter A, Tyring SK, Gordon K, Kimball AB, Leonardi CL, Langley RG, Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial. J Am Acad Dermatol. 2008;58:106–115.
- Gordon K, Korman N, Frankel E, Wang H, Jahreis A, Zitnik R, Efficacy of etanercept in an integrated multistudy database of patients with psoriasis. J Am Acad Dermatol. 2006;54(suppl):S101–S111.
- Sizto S, Bansback N, Feldman SR, Willian MK, Anis AH. Economic evaluation of systemic therapies for moderate to severe psoriasis. Br J Dermatol. 2009;160:1264–1272.